Severe acute cardiotoxicity following two intravenous doses of cyclophosphamide in an adolescent treated for rapidly progressive glomerulonephritis

Kardiol Pol. 2016;74(9):1027. doi: 10.5603/KP.2016.0123.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intravenous
  • Adolescent
  • Cardiomyopathy, Dilated / chemically induced*
  • Cardiomyopathy, Dilated / diagnosis
  • Cardiomyopathy, Dilated / therapy
  • Cardiotoxicity
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / adverse effects*
  • Cyclophosphamide / therapeutic use
  • Defibrillators, Implantable
  • Female
  • Glomerulonephritis / drug therapy*
  • Heart Failure / chemically induced
  • Heart Failure / diagnosis
  • Humans
  • Tachycardia, Sinus / chemically induced
  • Tachycardia, Sinus / diagnosis
  • Tachycardia, Sinus / therapy

Substances

  • Cyclophosphamide